Biobanking of CSF: International standardization to optimize biomarker development

Clinical Biochemistry

Volumn 47, Issue 4-5, 2014, Pages 288-292

  Teunissen, Charlotte E ^a   Tumani, Hayrettin ^b   Engelborghs, Sebastiaan ^c,e   Mollenhauer, Brit ^d,f  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY HOSPITAL ULM   (Germany)

^c UNIVERSITY OF ANTWERP   (Belgium)

^d Paracelsus Elena Klinik   (Germany)

^e Memory Clinic   (Belgium)

^f UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Biobanking; Biomarker studies; Cerebrospinal fluid; Consensus protocols; Control groups; Quality control

Indexed keywords

BIOLOGICAL MARKER; CYSTATIN C;

ALZHEIMER DISEASE; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; CEREBROSPINAL FLUID; DISEASE CONTROL; LUMBAR PUNCTURE; MULTIPLE SCLEROSIS; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEOMICS; QUALITY CONTROL; SPINAL ANESTHESIA; STANDARDIZATION;

BIOBANKING; BIOMARKER STUDIES; CEREBROSPINAL FLUID; CONSENSUS PROTOCOLS; CONTROL GROUPS; QUALITY CONTROL;

BIOLOGICAL MARKERS; BIOLOGICAL SPECIMEN BANKS; CONSENSUS; CONTROL GROUPS; CONTROLLED CLINICAL TRIALS AS TOPIC; COOPERATIVE BEHAVIOR; GUIDELINES AS TOPIC; HUMANS; NEURODEGENERATIVE DISEASES; QUALITY CONTROL; RESEARCH DESIGN; SPECIMEN HANDLING;

EID: 84896035180     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.12.024     Document Type: Article

References (22)

1. Berven F.S., Kroksveen A.C., Berle M., Rajalahti T., Flikka K., Arneberg R., et al. Pre-analytical influence on the low molecular weight cerebrospinal fluid proteome. Proteomics - Clinical Applications 2007, 1:699-711.
2. Blennow K., Wallin A., Hager O. Low frequency of post-lumbar puncture headache in demented patients. Acta Neurol Scand 1993, 88:221-223.
3. Buchhave P., Minthon L., Zetterberg H., et al. Cerebrospinal fluid levels of beta-amyloid 1-42, but not of tau, are fully changed already 5 to 10years before the onset of Alzheimer dementia. Arch Gen Psychiatry 2012, 69:98-106.
4. Carrette O., Burkhard P.R., Hughes S., Hochstrasser D.F., Sanchez J.C. Truncated cystatin C in cerebrospiral fluid: Technical [corrected] artefact or biological process?. Proteomics 2005, 5:3060-3065.
5. Deisenhammer F., Bartos A., Egg R., Gilhus N.E., Giovannoni G., Rauer S., et al. Guidelines on routine cerebrospinal fluid analysis. Report from an EFNS task force. Eur J Neurol 2006, 13:913-922.
6. Deisenhammer F., Egg R., Giovannoni G., Hemmer B., Petzold A., Sellebjerg F., et al. EFNS guidelines on disease-specific CSF investigations. Eur J Neurol 2009, 16:760-770.
7. Del Campo Milan M., Mollenhauer B., Bertolotto A., Engelborghs S., Hampel H., Simonsen A.H., et al. Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update. Biomark Med 2012, 6:419-430.
8. Greitz D., Hannerz J. A proposed model of cerebrospinal fluid circulation: observations with radionuclide cisternography. AJNR Am J Neuroradiol 1996, 17:431-438.
9. Jack C.R., Knopman D.S., Jagust W.J., Petersen R.C., Weiner M.W., Aisen P.S., et al. Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol 2013, 12:207-216.
10. Lachno D.R., Evert B.A., Vanderstichele H., Robertson M., Demattos R.B., Konrad R.J., et al. Validation of assays for measurement of amyloid-beta peptides in cerebrospinal fluid and plasma specimens from patients with Alzheimer's disease treated with solanezumab. J Alzheimers Dis 2013, 34:897-910.
11. Link H., Tibbling G. Principles of albumin and IgG analyses in neurological disorders. III. Evaluation of IgG synthesis within the central nervous system in multiple sclerosis. Scand J Clin Lab Invest 1977, 37:397-401.
12. Otto M., Bowser R., Turner M., Berry J., Brettschneider J., Connor J., et al. Roadmap and standard operating procedures for biobanking and discovery of neurochemical markers in ALS. Amyotroph Lateral Scler 2012, 13:1-10.
13. Petzold A. Intrathecal oligoclonal IgG synthesis in multiple sclerosis. J Neuroimmunol 2013, 262:1-10.
14. Redzic Z.B., Preston J.E., Duncan J.A., Chodobski A., Szmydynger-Chodobska J. The choroid plexus-cerebrospinal fluid system: from development to aging. Curr Top Dev Biol 2005, 71:1-52.
15. Reiber H., Felgenhauer K. Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chim Acta 1987, 163:319-328.
16. Schoonenboom N.S., Reesink F.E., Verwey N.A., Kester M.I., Teunissen C.E., van de Ven P.M., et al. Cerebrospinal fluid markers for differential dementia diagnosis in a large memory clinic cohort. Neurology 2012, 78:47-54.
17. Serot J.M., Zmudka J., Jouanny P. A possible role for CSF turnover and choroid plexus in the pathogenesis of late onset Alzheimer's disease. J Alzheimers Dis 2012, 30:17-26.
18. Teunissen C., Menge T., Altintas A., Alvarez-Cermeno J.C., Bertolotto A., Berven F.S., et al. Consensus definitions and application guidelines for control groups in cerebrospinal fluid biomarker studies in multiple sclerosis. Mult Scler 2013, 19:1802-1809.
19. Teunissen C.E., Petzold A., Bennett J.L., Berven F.S., Brundin L., Comabella M., et al. A consensus protocol for the standardization of cerebrospinal fluid collection and biobanking. Neurology 2009, 73:1914-1922.
20. Teunissen C.E., Tumani H., Bennett J.L., Berven F.S., Brundin L., Comabella M., et al. Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies. Mult Scler Int 2011, 2011:246412.
21. Vanderstichele H., Bibl M., Engelborghs S., Le B.N., Lewczuk P., Molinuevo J.L., et al. Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative. Alzheimers Dement 2012, 8:65-73.
22. Zetterberg H., Tullhog K., Hansson O., Minthon L., Londos E., Blennow K. Low incidence of post-lumbar puncture headache in 1,089 consecutive memory clinic patients. Eur Neurol 2010, 63:326-330.